Gains and losses from dexamethasone for neonatal chronic lung disease
- 1 September 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 352 (9131) , 835-836
- https://doi.org/10.1016/s0140-6736(05)60002-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung diseaseArchives of Disease in Childhood: Fetal & Neonatal, 1998
- Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurityActa Paediatrica, 1998
- Inhaled versus systemic steroids in chronic oxygen dependency of preterm infantsEuropean Journal of Pediatrics, 1996
- Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome.Archives of Disease in Childhood: Fetal & Neonatal, 1996
- Meta-analysis: A method for synthesizing research*Clinical Pharmacology & Therapeutics, 1995
- Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infantThe Journal of Pediatrics, 1995
- Influence of Postnatally Administered Glucocorticoids on Rat Lung GrowthNeonatology, 1995
- Two Doses of Early Intravenous Dexamethasone for the Prevention of Bronchopulmonary Dysplasia in Babies with Respiratory Distress SyndromePediatric Research, 1994
- Dexamethasone and hypertension in preterm infantsEuropean Journal of Pediatrics, 1992
- A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary DysplasiaNew England Journal of Medicine, 1989